2Seventy Bio Inc.

TSVTStocksPharmaceuticals MajorUnited StatesNasdaqUSD

Price

$5.01

Today

+0.0%

YTD

+0.4%

About

2seventy bio, Inc. is a cell and gene therapy-based company that researches, develops and commercialises cancer treatments. Incorporated in 2021, the 2seventy bio is headquartered in Cambridge, Massachusetts. The company operates locally in the United States. 2seventy bio was initially part of Bluebird, Inc. As of 4 November 2021, the company is an independent public trading entity. 2seventy bio’s oncology treatment products include idecabtagene vicleucel, ide-cel, or Abecma, and CAR-T cell treatment candidates to target multiple myeloma. The company has a collaboration agreement with Bristol-Myers Squibb Company. 2seventy bio trades under the TSVT ticker on the NASDAQ. Monitor the TSVT share price by adding this company to your eToro watchlist.

Price chart

Closing price history for TSVT (1D candles).

Open positions

Current open positions for this instrument from your live portfolio.

Open positions

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-49.12

P/S (TTM)5.52

P/B (TTM)1.23

Market cap$266.15M

Cap tierMicro-cap

Industry avg P/E-43.26

Profitability

Gross margin41.68%

EBIT margin-122.71%

Net margin2.10%

ROE-1.94%

ROA-0.83%

Earnings & Revenue

Revenue (TTM)$48.37M

Revenue growth (1Y)-32.1%

EPS (TTM)-$0.10

Free cash flow$-54.19M

Total debt$239.76M

Dividends & Risk

Dividend rate$0.00

Dividend yield0.00%

Beta (5Y)1.09

Employees65

Next earnings6 Aug '25

Trade history

Closed trades

Realized return

+0.0%

No stored closed trades exist for this instrument yet.